| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |